The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Susan Goodin

Division of Pharmaceutical Sciences

the Cancer Institute of New Jersey

and University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School

195 Little AlbanyStreet

USA

[email]@umdnj.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Pharmaceutical Sciences, the Cancer Institute of New Jersey, and University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, 195 Little AlbanyStreet, USA. 2006 - 2008
  • Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, USA. 2008
  • The Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. 2002 - 2008
  • Department of Medicine, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, New Brunswick, NJ 08903-2681, USA. 2004 - 2007
  • Medical Oncology, the Cancer Institute of New Jersey, 195 Little Albany Street, Room 2012, USA. 2007
  • Division of Pharmaceutical Sciences, The Cancer Institute of New Jersey, USA. 2005

References

  1. Development of monoclonal antibodies for the treatment of colorectal cancer. Goodin, S. Am. J. Health. Syst. Pharm (2008) [Pubmed]
  2. Ixabepilone: a novel microtubule-stabilizing agent for the treatment of metastatic breast cancer. Goodin, S. Am. J. Health. Syst. Pharm (2008) [Pubmed]
  3. Novel cytotoxic agents: epothilones. Goodin, S. Am. J. Health. Syst. Pharm (2008) [Pubmed]
  4. Progress in the development of monoclonal antibody therapies for colorectal cancer. Introduction. Goodin, S. Am. J. Health. Syst. Pharm (2008) [Pubmed]
  5. Clinical and biological activity of soy protein powder supplementation in healthy male volunteers. Goodin, S., Shen, F., Shih, W.J., Dave, N., Kane, M.P., Medina, P., Lambert, G.H., Aisner, J., Gallo, M., DiPaola, R.S. Cancer Epidemiol. Biomarkers Prev. (2007) [Pubmed]
  6. Oral chemotherapeutic agents: understanding mechanisms of action and drug interactions. Goodin, S. Am. J. Health. Syst. Pharm (2007) [Pubmed]
  7. Current issues associated with oral chemotherapy: a roundtable discussion. Goodin, S., Aisner, J., Bartel, S.B., Viele, C.S. Am. J. Health. Syst. Pharm (2007) [Pubmed]
  8. Erlotinib: optimizing therapy with predictors of response?. Goodin, S. Clin. Cancer Res. (2006) [Pubmed]
  9. Selecting an anticoagulant for recurrent venous thromboembolism in cancer. Goodin, S. Am. J. Health. Syst. Pharm (2005) [Pubmed]
  10. NSAIDs for the chemoprevention of oral cancer: promise or pessimism?: Commentary re J. L. Mulshine et al., randomized, double-blind, placebo-controlled, phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin. Cancer Res., 10: 1565-1573, 2004. Goodin, S., Shiff, S.J. Clin. Cancer Res. (2004) [Pubmed]
  11. 5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile. Goodin, S., Cunningham, R. Oncologist (2002) [Pubmed]
 
WikiGenes - Universities